Lifecore Biomedical Inc
NASDAQ:LFCR
Lifecore Biomedical Inc
NASDAQ:LFCR
Price:
6.58
USD
-1.05%
Market Closed
Market Cap:
243.7m
USD
Balance Sheet
Balance Sheet Decomposition
Lifecore Biomedical Inc
Lifecore Biomedical Inc
| Current Assets | 81.9m |
| Cash & Short-Term Investments | 9.5m |
| Receivables | 30.3m |
| Other Current Assets | 42.1m |
| Non-Current Assets | 173.5m |
| PP&E | 152.9m |
| Intangibles | 18.1m |
| Other Non-Current Assets | 2.6m |
Balance Sheet
Lifecore Biomedical Inc
Lifecore Biomedical Inc
Currency: USD
Millions
Annual
| May-2015 | May-2016 | May-2017 | May-2018 | May-2019 | May-2020 | May-2021 | May-2022 | May-2023 | May-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
14
|
10
|
5
|
3
|
1
|
0
|
1
|
2
|
19
|
8
|
|
| Cash Equivalents |
14
|
10
|
5
|
3
|
1
|
0
|
1
|
2
|
19
|
8
|
|
| Total Receivables |
47
|
46
|
47
|
54
|
70
|
76
|
70
|
48
|
29
|
31
|
|
| Accounts Receivables |
47
|
46
|
47
|
54
|
70
|
76
|
70
|
48
|
29
|
31
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
25
|
26
|
25
|
32
|
54
|
66
|
70
|
67
|
41
|
40
|
|
| Other Current Assets |
7
|
5
|
4
|
9
|
8
|
14
|
7
|
7
|
5
|
1
|
|
| Total Current Assets |
93
|
86
|
81
|
97
|
133
|
157
|
148
|
124
|
94
|
81
|
|
| PP&E Net |
85
|
121
|
133
|
160
|
200
|
218
|
200
|
127
|
139
|
151
|
|
| PP&E Gross |
85
|
0
|
133
|
160
|
200
|
218
|
200
|
127
|
139
|
151
|
|
| Accumulated Depreciation |
50
|
0
|
60
|
69
|
80
|
95
|
103
|
49
|
57
|
50
|
|
| Intangible Assets |
56
|
21
|
23
|
22
|
45
|
38
|
36
|
10
|
4
|
4
|
|
| Goodwill |
50
|
50
|
55
|
55
|
77
|
69
|
69
|
14
|
14
|
14
|
|
| Long-Term Investments |
62
|
63
|
64
|
67
|
61
|
57
|
45
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
2
|
3
|
5
|
3
|
2
|
4
|
3
|
3
|
4
|
|
| Other Assets |
50
|
50
|
55
|
55
|
77
|
69
|
69
|
14
|
14
|
14
|
|
| Total Assets |
347
N/A
|
343
-1%
|
359
+5%
|
405
+13%
|
519
+28%
|
541
+4%
|
503
-7%
|
278
-45%
|
254
-9%
|
254
+0%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
35
|
31
|
26
|
35
|
54
|
52
|
48
|
16
|
22
|
16
|
|
| Accrued Liabilities |
11
|
13
|
17
|
19
|
21
|
23
|
24
|
19
|
12
|
19
|
|
| Short-Term Debt |
0
|
4
|
3
|
27
|
52
|
77
|
29
|
40
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
8
|
8
|
5
|
5
|
10
|
12
|
0
|
102
|
1
|
1
|
|
| Other Current Liabilities |
2
|
1
|
0
|
3
|
1
|
0
|
1
|
1
|
4
|
2
|
|
| Total Current Liabilities |
56
|
56
|
52
|
88
|
137
|
164
|
102
|
177
|
39
|
39
|
|
| Long-Term Debt |
34
|
50
|
46
|
41
|
91
|
105
|
168
|
0
|
104
|
124
|
|
| Deferred Income Tax |
34
|
22
|
25
|
18
|
19
|
14
|
6
|
0
|
0
|
1
|
|
| Minority Interest |
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2
|
2
|
8
|
5
|
2
|
28
|
24
|
10
|
75
|
37
|
|
| Total Liabilities |
128
N/A
|
132
+3%
|
132
+0%
|
152
+15%
|
249
+64%
|
310
+25%
|
300
-3%
|
187
-38%
|
218
+17%
|
200
-8%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
39
|
43
|
|
| Retained Earnings |
85
|
74
|
85
|
109
|
110
|
71
|
39
|
76
|
179
|
167
|
|
| Additional Paid In Capital |
133
|
137
|
142
|
142
|
160
|
163
|
166
|
167
|
174
|
178
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
3
|
1
|
1
|
0
|
0
|
|
| Total Equity |
218
N/A
|
211
-4%
|
227
+8%
|
253
+11%
|
270
+7%
|
231
-14%
|
203
-12%
|
91
-55%
|
35
-61%
|
54
+54%
|
|
| Total Liabilities & Equity |
347
N/A
|
343
-1%
|
359
+5%
|
405
+13%
|
519
+28%
|
541
+4%
|
503
-7%
|
278
-45%
|
254
-9%
|
254
+0%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
27
|
27
|
28
|
28
|
29
|
29
|
29
|
30
|
30
|
31
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
